8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
about
A new standard of care for the management of peritoneal surface malignancyChinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignanciesSurgery for Colorectal Cancer - Trends, Developments, and Future PerspectivesEvolution of management in peritoneal surface malignanciesTreatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectivesCytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review-past, present and futureRepeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: review of indications and outcomesCytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortalityCytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastric cancer and other less common disease histologies: is it time?Preoperative and surveillance MR imaging of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapyThen and now: cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC), a historical perspectiveMultimodality treatment strategies have changed prognosis of peritoneal metastasesAbdominal metastases from colorectal cancer: intraperitoneal therapyOutcome following incomplete surgical cytoreduction combined with intraperitoneal chemotherapy for colorectal peritoneal metastasesColorectal cancer: Metastases to a single organTreatment of peritoneal metastases from colorectal cancerThe Increasing Relevance of Tumour Histology in Determining Oncological Outcomes in Colorectal CancerLooking up: Recent advances in understanding and treating peritoneal carcinomatosisMultimodal treatment approaches for peritoneal carcinosis in colorectal cancerExtravascular use of drug-eluting beads: a promising approach in compartment-based tumor therapyTherapeutic options for peritoneal metastasis arising from colorectal cancerPathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneumHyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Management of Peritoneal CarcinomatosisStrategies to prevent peritoneal carcinomatosis arising from colorectal cancer.Photodynamic Detection of Peritoneal Metastases Using 5-Aminolevulinic Acid (ALA).Peritoneal Carcinomatosis from Colon Cancer: A Systematic Review of the Data for Cytoreduction and Intraperitoneal ChemotherapyClosed abdomen hyperthermic intraperitoneal chemotherapy with irinotecan and mitomycin C: a phase I study.Critical care management and intensive care unit outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in miceOxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): a dose-finding study and pharmacogenomic analysis.Specific genomic aberrations in primary colorectal cancer are associated with liver metastasesMetastatic colorectal cancer: survival comparison of hepatic resection versus cytoreductive surgery and hyperthermic intraperitoneal chemotherapyPost-menopausal vaginal bleeding caused by carcinoma of the appendix: a case report.Anaesthesia in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: retrospective analysis of a single centre three-year experience.Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).Current treatment options for colon cancer peritoneal carcinomatosis.Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal metastases.Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy aloneMultidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer.Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial.
P2860
Q24626790-AD62F95A-2B3A-49D5-A231-53594778B8F3Q26738517-10069CEA-8669-4630-8242-E004F8E43650Q26738796-2788DB38-DC7C-4356-A612-6ABF66BBDFD8Q26741293-989887FB-983A-4BFD-8FC4-8DBF59BF4CB3Q26744031-D93C95F2-EB56-44AF-BE9E-695DE6512DEAQ26768296-DC73F2FA-AB61-4B54-9565-AABE3FF49136Q26768299-67D50449-310F-4FAD-A511-96D1E0E43EACQ26768309-6DBE3006-2C79-4A12-8189-B691C4B2DCDFQ26768312-0CD9D37F-0DD7-4CE2-AE78-E174F22AAA08Q26768400-91A6F486-7053-4762-A023-D6CD3B5D78BEQ26768408-4D762442-B009-4CFC-AED5-C5440FCE21A5Q26769938-8FA1586F-FDEA-48E9-B2D1-BC481223FB43Q26772268-32ABA668-ED2E-4373-AEE8-6B0A72AC91FEQ26774607-4A35602E-E3C3-4F30-A855-6F801ADCBCCEQ26778009-A8C0FAD9-DD54-4148-B8F6-1A3579EF4B19Q26783662-05F94C8E-6DD9-4CF3-8E31-9BE908620544Q26796255-81513F8A-CED6-4895-A5F4-3D735CB90D5CQ26849259-ECEA657F-ED54-4B5B-A75E-980F05ED0B80Q26852135-538A1D3A-A05E-4BBC-BA56-42E9A6A93669Q27000814-1F8FB4C6-0786-49C3-8462-52505E0ADCADQ28067123-B579508A-4AD4-4365-8EA6-C490BA87AC4EQ28073129-4CC2F86A-EED5-4C73-8FC9-0BE24F8C21C3Q28077394-ADCC6423-6522-47F8-AE0F-8EB2B1479AAFQ30239825-E7E6A0CD-B925-40FD-8139-136F3089603BQ30572371-9419AC93-9C86-4205-B19C-CC6236FE932DQ31031044-74FD9E7F-92FA-4E7D-9D1A-5A59162EA406Q33394590-AFF1C067-72CB-4B9F-B045-A6AE78738661Q33634993-11391E09-1689-48DC-A0BB-ED0F6149683DQ33647418-48B32CFC-B37D-430E-804A-6F6BACC7CD51Q33747440-7E0815CE-E7CC-489E-9D5E-10062D5923F8Q33761768-CD93B9A0-B826-44FF-888D-1E47F59D431DQ33850248-44455C08-0722-4DBD-8CA0-305D439BA29FQ33864221-8C485AF9-9ED3-4D99-9D6A-155B3B494804Q33960679-DB324A03-3BF5-4941-87E6-778E331C96A3Q34130132-16B69844-E580-46AC-9C26-0D753CA42A80Q34207816-20D8B618-1275-4B1B-9F76-725DCF61A1CAQ34326741-6FDC3349-B19A-4A07-BD9C-105C29E90C41Q34354500-F40483C2-B042-4698-9524-11EA6ACBED07Q34390124-B65730ED-E797-4D32-AA0A-E3D6FF792D04Q34477640-0FF7D2D8-6D66-4F29-B577-99451B8E6DBF
P2860
8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
8-year follow-up of randomized ...... omatosis of colorectal cancer.
@en
8-year follow-up of randomized ...... omatosis of colorectal cancer.
@nl
type
label
8-year follow-up of randomized ...... omatosis of colorectal cancer.
@en
8-year follow-up of randomized ...... omatosis of colorectal cancer.
@nl
prefLabel
8-year follow-up of randomized ...... omatosis of colorectal cancer.
@en
8-year follow-up of randomized ...... omatosis of colorectal cancer.
@nl
P2093
P1476
8-year follow-up of randomized ...... omatosis of colorectal cancer.
@en
P2093
Gooike van Slooten
Harm van Tinteren
Sjoerd Bruin
Vic J Verwaal
P2860
P2888
P304
P356
10.1245/S10434-008-9966-2
P577
2008-06-03T00:00:00Z
P6179
1030091417